Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 1 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar IBDContrarian (< 20) Submitted: 6/27/2012 1:57:10 PM : Underperform Start Price: $13.60 INFI Score: -54.39

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yieldMEDICAL 9 97 EB- NEG EARNINGS

Report this Post 1 Reply
Member Avatar IBDContrarian (< 20) Submitted: 12/18/2012 10:39:17 AM
Recs: 0

36 99 EA-, still NO EARNING

Report this Post

Featured Broker Partners


Advertisement